Over the last decades, a better knowledge of the molecular machinery supervising the regulation of circadian clocks has been achieved, and numerous findings have helped in unravelling the outstanding significance of the molecular clock for the proper regulation of our physiologic and metabolic homeostasis. Non-alcoholic fatty liver disease (NAFLD) is currently considered as one of the emerging liver pathologies in the Western countries due to the modification of eating habits and lifestyle. Although NAFLD is considered a pretty benign condition, it can progress towards non-alcoholic steatohepatitis (NASH) and eventually hepatocellular carcinoma (HCC). The pathogenic mechanisms involved in NAFLD development are complex, since this disease is a multifactorial condition. Major metabolic deregulations along with a genetic background are believed to take part in this process. In this light, the aim of this review is to give a comprehensive description of how our circadian machinery is regulated and to describe to what extent our internal clock is involved in the regulation of hormonal and metabolic homeostasis, and by extension in the development and progression of NAFLD/NASH and eventually in the onset of HCC.
Introduction

NAFLD
Definition, epidemiology and economic burden
The histopathological characteristics of non-alcoholic fatty liver disease (NAFLD) are similar to those observed in alcoholic fatty liver disease (ALFD), but alcohol consumption has to be lower than 0-20 g/day [1, 2] . NAFLD is a multifactorial disorder, since it encompasses a wide spectrum of liver damages, from simple steatosis (non-alcoholic fatty liver BNAFL^) to steatohepatitis (non-alcoholic steatohepatitis, BNASH^). NAFL is considered a relatively nonthreatening condition with a limited risk of further progression. On the contrary, NASH is often associated with fibrosis and may potentially progress to irreversible cirrhosis (stage of fibrosis = 4) in 5-10 years and in some cases to liver failure or even to hepatocellular carcinoma (HCC) [3, 4] . Epidemiological data show that NAFLD is the most frequent chronic liver disease worldwide, both in children and in adults, becoming over the past decade a major public health problem, which will represent a serious clinical and economic burden, especially in Western countries [5] [6] [7] [8] . For example, one study estimated that the cost for public health systems is roughly € 35 billion/year in Europe (estimation done in four countries: UK, Germany, France and Italy) and USD 103 billion/year in the USA [9] . In addition, NAFLD patients show a worse quality of life if compared to healthy subjects due to clinic manifestations such as fatigue, somnolence and physical inactivity [10] . These factors very often result in decreased work productivity. If these factors are added to clinical aspects, the estimated economic burden rises to about € 200 billion/year in Europe and to USD 300 billion/year in the USA [9] . If in this picture the cost due to HCC is also added, the estimation rises to USD 500 billion/year just for the USA [9] . An important aspect to consider is that, due to the lag time needed to NAFLD to manifest and to progress to cirrhosis and to HCC, the real relevance of NAFLD-related diseases could have been underestimated [11] .
The prevalence of NAFLD in the general population may range from 20 to 30% [12] , whilst NASH is diagnosed approximately in 50-70% of patients with NAFLD [12] . These alarming data, which are expected to grow in the future due to the close association of NAFLD with obesity and metabolic syndrome (MetS), make this disease a major social and economic burden.
Diagnosis
NAFLD is diagnosed when simple steatosis is present without other causes of liver disease, such as viral and autoimmune hepatitis, alcohol or drug abuse, Wilson disease and α1-antitrypsin deficiency. Blood levels of transaminases, body mass index (BMI), waist circumference, glucose and triglyceride serum levels are often used as indirect non-invasive biomarkers [13] . For the diagnosis of NASH, liver biopsy is currently the golden standard, since it allows to discriminate between the different histological features of the disease and to determine the severity of liver damage and the presence and grading of fibrosis [14, 15] . Since liver biopsy presents some limitations (i.e. elevated risks of complications and high cost), an increasing number of non-invasive and possibly more efficient diagnostics approaches are under evaluation [16] , such as several serum biomarkers [17] [18] [19] .
Risk factors
Obesity, IR and the other disorders that define MetS are the major predisposing risk factors to NAFLD. MetS is characterised by obesity (BMI > 30), hypertension, type II diabetes, hypertriglyceridemia and low HDL cholesterol. NAFLD is largely believed as the hepatic manifestation of MetS, even if there is no agreement about the cause-effect relationship between NAFLD and MetS. However, the main risk factor associated with NAFLD is nowadays represented by obesity, to which the significant increase of NAFLD prevalence is ascribed, especially in paediatric subjects [20] . Nutrition and physical activity are important in determining the risk of NAFLD as well. In fact, lifestyle modifications represent a well-established approach for both prevention and treatment [21, 22] . Excessive food intake and insufficient exercise predisposes to weight gain contributing to the progression of NAFLD towards NASH and hepatic fibrosis [23] . As we will describe later in this review, most of these factors have been directly or indirectly associated to circadian rhythms.
Pathogenesis
Although the pathogenesis of NAFLD is not completely understood yet, several models have been proposed to explain its development and progression. According to the Bmultiple hits^hypothesis, Bprimary hits^such as insulin resistance (IR) and free fatty acid (FFA) accumulation may promote steatosis, making the liver susceptible to a wide range of Bsecondary hits^, such as oxidative stress, mitochondrial dysfunction, adipocytokines and cytokines, gut-derived products and activation of specific nuclear receptors, which may lead to NASH and eventually to fibrosis [24, 25] .
In genetically predisposed subjects, environmental factors and dietary habits may synergise through two potential mechanisms: (i) induction of systemic IR that may cause an excessive FFA accumulation in the liver and muscle; (ii) increase of visceral fat deposition and consequently IR, in the liver first, and then at peripheral sites [26] . Hepatic FFA accumulation may occur in response to diet, lipolysis within adipose tissue and de novo lipogenesis. In this context, IR may increase FFA flux into the liver and FFA synthesis and decrease very-lowdensity lipoprotein (VLDL) packaging, with a resulting reduction in the hepatic FFA export [27] . Excessive caloric intake might function as a metabolic stress leading to the accumulation of unfolded proteins and endoplasmic reticulum (ER) stress in adipose tissue. This in turn may lead to cytokine production and release by adipocytes, with a local inflammatory action and effects on the liver as well [28, 29] . These adipose tissue-derived circulating molecules trigger an inflammatory response in liver-resident cells and activate a signalling cascade that leads to ROS production [30] . The resultant accumulation of lipotoxic metabolites together with the oxidative triglyceride disposal involving β-oxidation and lysosomes leads to hepatic damage and in an immune-mediated hepatocellular injury that eventually promotes NASH [31] .
Immune-mediated response in NAFLD involves not only adipocytokines, but also the microbiota-dependent increased permeability of the gut and the translocation of bacterial endotoxins, which once reach liver cells activate a proinflammatory state [32] . If the necrotic and apoptotic pathways and liver-resident cell inflammation last for a long time, liver tissue architecture may change towards a fibrotic phenotype upon activation and proliferation of hepatic stellate cells [33] .
Circadian rhythms
Historical background
An internal rhythmicity independent of environmental stimuli was first described in higher eukaryotes at the beginning of the eighteenth century by d'Ortous De Mairan. In Mimosa pudica, he observed a light-independent 24-h periodicity in the opening-closing cycles of leaves. More than one century later, Alphonse de Candolle in the same plant noticed that the leaf cycle was not precisely 24 h long. In the second half of the twentieth century, Bünning described a 24.4-h leaf cycle in Phaseolus coccineus [34] , and similarly, Pittendrigh et coll. found a 22-to 28-h daily cycle in Drosophila [35] [36] [37] .
Such discoveries brought to the light a keystone idea for the interpretation of circadian rhythmicity: the periodicity is Binnate^, and not provoked by external stimuli, with an average period of about 24 h. Such internal self-governing rhythms were designated Bfree-running^, since environmental stimuli are needed just for synchronisation. Light is the principal Btimer^(BZeitgeber^in German) that coordinates (Bentrain^) mammalian internal clocks with the external time.
The central oscillator
The first step for the localisation of the internal oscillator and the clarification of the physiological mechanisms involved was discovering that rats with lesioned hypothalamus lost behavioural rhythmicity [38, 39] . The central pacer was successively localised in the suprachiasmatic nucleus (SCN), a small group of cells in the anterior hypothalamus [40] (Fig. 1) . The neural link between the eye and the SCN was termed Bretinohypothalamic tract^(RHT) [41] (Fig. 1) . The SCN intrinsically produces a periodic 24-h electrical activity, which in turn generates an equivalent pattern in neighbour neurons [42] [43] [44] . Light entrains retinal inputs at the central nervous system (CNS) level (Fig. 1) independently to rods and cones, since retinal ganglion cells innervating the CNS are intrinsically photosensitive and respond to light in the absence of synaptic inputs from such photoreceptors [45] .
The SCN transmits signals in the peripheral districts of the body by three principal routes: (i) physically, by directly interacting with other brain regions; (ii) chemically, through the production of signalling molecules; and (iii) indirectly, by determining rest-activity periods that in turn regulate feedingfasting rhythms, of central relevance for the setting of the clock of several peripheral organs [46, 47] . In fact, the SCN directly interacts with the subparaventricular zone (sPVZ) [48, 49] , the preoptic area (POA), the bed nucleus of the stria terminalis (BNST), the lateral septum (LS), the dorsomedial hypothalamus (DMH), the arcuate nucleus (ARC) and the paraventricular nucleus (PVN) [48, 49] (Fig. 1) 
The molecular clock machinery
The molecular circadian machinery was pinpointed in Drosophila and in mice. The first gene to be determined was period (Per), since mutant flies showed an atypical eclosion time [58] . The protein PER was synthesised rhythmically and synchronised with the circadian behaviour of the fly [59] . Three other proteins were found later: (i) the product of the timeless (Tim) gene, TIM [60, 61]; (ii) CLOCK, the product of clock gene [62] ; and (iii) CYCLE (CYC), the product of cycle gene [63] . In Drosophila, the CLOCK·CYCLE complex binds to the E-box region on Per and Tim promoters, thus triggering their transcription. As PER and TIM level increases, the PER·TIM complex interacts with CLOCK· CYCLE, preventing its transcriptional activator activity. Once the transcription is blocked, a novel cycle of synthesis starts. This mechanism is further ameliorated by the doubletime (DBT) protein kinase, which phosphorylates PER, tagging it for proteasomal degradation.
Once activated by light, cryptochrome (CRY) and opsin lead to TIM degradation, which in turn retunes the system [64] . In mice, three Per homologue genes (mPer1-3) have been discovered, whose transcription is activated by light with a nearly 24-h period [65] [66] [67] .
The mammalian homologue of cycle is Bmal1 [68] . In mammals, Cry has two isoforms, Cry1 and Cry2. Even if not directly involved in the reception of light, Cry is essential for the feedback mechanism [69] [70] [71] . Further regulators, RevErb α/β and retinoic acid-related orphan receptor α/β (ROR α/β), refine the mechanism by interacting with the ROR/REV-ERB-response element (RORE) in the Bmal1 gene and repressing and stimulating its transcription, respectively [72] [73] [74] [75] . Although previously believed not fundamental for the production of circadian rhythmicity, now, they are recognised to play a key role [76] . The mammalian analogues of Drosophila DBT are casein kinase 1ε (CK1ε) and casein kinase 1δ (CK1δ), which, as a complex (CK1δ/ε), phosphorylate PER proteins, tagging them to proteasome for degradation [77, 78] .
Thus, in mammals, the light is caught by both Bclassicalp hotoreceptors and by the photoreceptor melanopsin, situated in the retinal ganglion cells [45, 79, 80] (Fig. 1 ). Light in turn stimulates a sequence of responses that reset the clock by inducing mPer1-2 transcription [81] [82] [83] . The de novo synthesised PER proteins, after binding to CRY, enter into the nucleus, where the PER·CRY complex inhibits the transcription of clock-controlled genes (ccg) and of their own genes [84, 85] . A supplementary checkpoint is the CK1δ/ε-mediated PER· CRY phosphorylation, which directs the complex to proteasomal degradation. In mouse liver, CLOCK also acetylates BMAL1 facilitating CRY1 recruitment to CLOCK-BMAL1 and eliciting transcriptional repression. This interaction is crucial for the correct functioning of the circadian mechanism [84, 85] .
Peripheral organs clocks
The molecular repertoire that governs the circadian rhythmicity is found not only in the SCN, but in almost all peripheral tissues [86] . Such peripheral rhythms, however, depend upon the activity of the central oscillator, since in vitro, without the contribution of the SCN, they stop after 2-7 cycles in the liver, lung and skeletal muscle [86] . Isolated peripheral tissues can selfsustain a circadian periodicity up to 20 cycles; therefore, peripheral organs express at least a partially self-working circadian pacemaker [87] . Such circadian behaviour was documented also in vitro in numerous cell types [88] [89] [90] [91] , and in tissue explants from nearly all the organs [87, 92] . Interestingly, the brain itself possesses its own circadian oscillation in the expression of several genes that seems to be independent of the activity of the SCN [93, 94] . A broad bioinformatics analysis in mice allowed the identification of 41 genes oscillating in a circadian manner in several tissues. Actually, approximately 2-10% of the entire genome displays a circadian pattern of expression and part of such genes is tissue-specifically expressed. Nonetheless, almost all tissues share a relevant part of them. Periodicity genes, such as Per2, Bmal1, Rev-erbα and Cry, show the higher degree of conservation [95] .
Synchronisation of peripheral organs clocks
Three ways of entrainment in the synchronisation of peripheral clocks have been identified: (i) direct SCN entrainment by neural and hormonal signals; (ii) feeding-fasting rhythms entrainment; (iii) body temperature entrainment.
(i) Neural control is achieved by the autonomic nervous system whose outputs are in turn indirectly controlled by the SCN. The actual SCN involvement in this regulation and which mechanisms might be involved is still under evaluation. Injuries in the SCN eliminate circadian feeding and drinking schedules [40] . In mouse liver, roughly 9% out of about 2000 genes show a clear circadian pattern, and removing SCN compromised rhythmical expression of hepatic circadian genes [96] . In rats surgically deprived of autonomic liver innervation, light was not able to induce Per1/2, Pepck and Glut2 upregulation [97] . In SCN-deprived rats, light could not activate the sympathetic-driven corticosterone release by the adrenal gland [98] , and the hyperglycaemic effect of GABA antagonists was lost [99] .
(ii) Feeding-fasting rhythms are central for the entrainment of several peripheral organs, such as the heart, kidney, pancreas and liver. In mouse liver, the majority of metabolismcontrolling genes are expressed Bcircadianly^ [100] , and in rats, the inversion of feeding rhythms substantially modified the expression of hepatic metabolic genes [101] . In Cry1/2-deficient mice, temporally restricted feeding restored the circadian transcriptional periodicity of the majority of the hepatic genes. On the other hand, without a feeding schedule, animals kept the transcriptional periodicity just of a minimal portion of the usual circadian-expressed genes [47] . Feeding/fasting circadian rhythm regulation in peripheral tissues is also controlled by hormones such as peptide YY, oxyntomodulin, cholecystokinin, leptin and ghrelin, which directly signal to the arcuate nucleus (reviewed in [102] ).
(iii) Circadian clock regulation by temperature is up to now not completely understood. In mice, the SCN compensates for temperature fluctuations of the external and internal environment, probably through CRY and PER [103] . Similarly, in cultured fibroblasts from both humans and mice, simulated body temperature cycles, with daily temperature differences of 3°C and 1°C, respectively, synchronised circadian gene expression. After few days, gene expression was synchronised with temperature cycles, and such temperature rhythms also entrained gene expression cycles to periods longer or shorter than 24 h [104] . Consequently, working synergistically to coordinate circadian phases, light and temperature regulate the clock, contributing to its seasonal adaptations.
Circadian clock and metabolism regulation
Over the last years, the knowledge of the role of circadian rhythms on metabolic homeostasis has significantly developed [105] [106] [107] . A significant role is played by SIRT1, a member of SIRT deacetylase family [108] (Fig. 2) . SIRT1 activity needs NAD + as a cofactor; therefore, during fasting, when NAD + level is increased, SIRT1 activity is higher [108] . SIRT1-driven NAD + -dependent histone deacetylation of BMAL1 and PER2 generates a repressive chromatin state [109] . SIRT1 binds to CLOCK and is directed at the CLOCK·BMAL1 chromatin complex at the circadian promoters. Genetic Sirt1 ablation or pharmacological inhibition desynchronised the circadian rhythmicity. Consequently, SIRT1 was suggested to control the circadian machinery, sensing modifications at cellular metabolite level [110] . Of note, t h e c i r c a d i a n e x p r e s s i o n o f n i c o t i n a m i d e phosphoribosyltransferase (NAMPT) mediated by CLOCK· BMAL1 results in circadian oscillations of intracellular NAD + levels (Fig. 2 ). SIRT1 then binds to the Nampt promoter, upregulating the synthesis of its own coenzyme [111] . SIRT1 regulates transcription of several clock genes, such as Bmal1, Per2, Cry1, and Rorγ and binds CLOCK·BMAL, promoting PER2 deacetylation and degradation. Since SIRT1-deacetylase activity depends upon NAD + levels, SIRT1 may connect cellular metabolism and circadian machinery [112] . In the brain, SIRT1 activates Bmal1 and Clock transcription through a positive feedback involving SIRT1, PGC-1α, and NAMPT. In aged mice with decreased SCN levels of SIRT1, BMAL1 and PER2, the dysregulated pattern of activity and light entrainment was not observed in the SCN SIRT1-overexpressing mice [113] . AMPK is a multi-protein complex that works as a general stimulator of catabolic processes and inhibitor of anabolic pathways. One of AMPK regulatory subunits, ampkβ2, shows a circadian expression pattern, which determines a periodic translocation into the nucleus, where it directly phosphorylates CRY1 together with LKB kinase. Such phosphorylation leads to CRY1 proteasomal degradation [114] . BMAL1 and CLOCK are essential for glucose and triglyceride homeostasis. In fact, Bmal1 deletion and Clock mutations impaired gluconeogenesis. Moreover, high-fat diet intensified circadian oscillations in insulin sensitivity and glucose tolerance [115] . During fasting, gluconeogenesis is activated by the cAMPmediated phosphorylation of cAMP response elementbinding protein (CREB) and CREB activity is under Cry1 and Cry2 control. Cry1 expression is high during the nightday transition, when it lowers fasting gluconeogenic gene expression through the inhibition of glucagon-mediated increase in intracellular cAMP and protein kinase A-mediated phosphorylation of CREB. Since hepatic overexpression of Cry1 decreases blood glucose concentrations and improves insulin sensitivity in insulin-resistant mice, molecular cryptochrome activity stimulators might prove useful as therapeutic agents for type II diabetes [116] .
The highly metabolically controlled transcription factor REV-ERBα is very important for circadian rhythm synchronisation [117] ; hence, synthetic REV-ERBα agonists might prove useful as positive regulators in metabolic pathologies. In fact, mice treated with synthetic REV-ERB agonist modifications showed an augmented energy expenditure in the liver, skeletal muscle and adipose tissue. Likewise, diet-induced obese mice treated with REV-ERB agonists showed reduced fat mass, hyperglycaemia and dyslipidaemia [118] . Interestingly, the activity of the stomach ghrelin-secreting cells is synchronised by food by a clock-based mechanism [119] . Moreover, glycogen synthase kinase-3 (GSK-3β) inhibition leads to a period shortening of the clock [120] .
Role of circadian rhythms in liver metabolism
Liver and pancreas clocks
The expression of several clock-and hepatic-specific genes is under circadian control, and circadian genes are central for liver functioning. For example, Bmal1-deficient mice lost the periodic behaviour in both the brain and the liver, whilst in Clock-deficient mice hepatic circadian clock was not functional, despite a preserved central periodicity [121] . Nevertheless, liver periodicity is relatively autonomous from the central regulator: in mice, for example, glucocorticoid receptors recovered nearly 60% of circadian gene expression lost after SCN damage [122] . Food also exerts an important role, at least partly not dependent from the presence of the central pacemaker, since more than 80% of the hepatic transcriptome was shown to be Bmeal-dependent^ [101] . The circadian molecular machine is essential for glucose homeostasis: in Bmal1-and Per1/2-deficient mice, liver-specific Bmal1 inactivation resulted in severe hypoglycaemia during the rest period. This was not seen if Bmal1 was inactivated in nonhepatic cell types [121] . A single-nucleotide polymorphisms (SNP) study performed in humans showed that Per2 was associated with high fasting blood glucose, whilst neuronal PAS domain-containing protein 2 (Npas2) with hypertension [123] . In mice, bile acid and cholesterol biosynthesis are under circadian control through Rev-Erbα, which regulates Srebp expression and therefore cholesterol metabolism. It was also suggested that the cyclic expression of cholesterol-7α-hydroxylase (Cyp7a1) might be regulated by a REV-ERBα-mediated mechanism, through an oxysterol-mediated LXR activation [124] .
An important role in the regulation of liver clock is played by the nuclear receptor small heterodimer partner (SHP). In Shp (−/−) mice, the expression of major hepatic metabolic genes and of several components of the hepatic circadian machinery, including peroxisome proliferator-activated receptor-γ coactivator 1 (Pgc-1α), Npas2, and Rorα/γ was increased. By interacting with RORγ, SHP inhibited Npas2 transcription and promoter activity to repress Rorγ transactivation and, by interacting with Rev-erbα, decreased RORα activity. On the other hand, by rhythmically binding to the Shp promoter, Npas2 controlled Shp expression, which is enhanced by nicotinamide adenine dinucleotide but not by nicotinamide adenine dinucleotide phosphate. Interestingly, Npas2 deficiency resulted in severe steatotic phenotype in Shp (−/−) mice, probably due to a dysregulation of lipoprotein metabolism [125] .
Worthy of mention is Nocturnin, a circadian-controlled deadenylase, that removes the poly(A) tail, posttranscriptionally controlling mRNA expression. What was shown is that Nocturnin-knockout mice are resistant to dietinduced obesity and hepatic steatoses [126] [127] [128] (Fig. 3) .
The existence of an independent circadian oscillator in the pancreas was recently demonstrated in mice. Bmal1 and Clock are essential, since their selective knockdown led to modifications of the proliferative rate and size of islet cells, along with hypoinsulinemia, reduced glucose tolerance and diabetes [129, 130] . Hence, deregulations of circadian rhythms in the pancreas could be also responsible for the onset of metabolic disorders, eventually predisposing to NAFLD development.
Role of circadian rhythms in NAFLD
As we extensively discussed above, the precise regulation and setting of our circadian clock is deeply linked to the proper functioning of our metabolic machine. Hence, deregulations of circadian rhythms may be involved in the onset of NAFLD, its progression to NASH and eventually to HCC (Fig. 3) .
Role of genetic background
Several research groups have addressed this point, and some aspects were brought to light. For example, a study performed in 136 NAFLD patients versus 64 healthy individuals determined six SNPs showing a minor allele frequency (> 10%) encompassing 117 kb of chromosome 4 and representing 115 polymorphic sites. Results highlighted that all SNPs showed a significant association with disease severity and could be involved in the progression to NASH, since a correlation with the development of fibrosis was observed. It is worth underlining here that the activation of hepatic stellate cells (HSC) could be controlled through a CLOCK-driven PPARγ and SREBP1-mediated mechanism [131] .
Single nucleotide polymorphisms (SNPs) studies and genome-wide association studies (GWAS) revealed some candidate genes that may confer susceptibility to NAFLD [132] [133] [134] . In particular, a GWAS study found that a SNP in Patatin-like phospholipase domain-coding protein (PNPLA3/ adiponutrin) has a strong association with NAFLD [135] . Moreover, other polymorphisms associated with oxidative stress and immune function are involved in determining susceptibility to NAFLD and NASH. Amongst these susceptibility genes, some as PNPLA3 modify hepatic fatty acid flux and triglyceride levels, whereas others influence progression to NASH and fibrosis [136] .
Involvement of hormonal homeostasis
Improper diet habits, drugs, hormonal unbalances or viruses can trigger NAFLD. Hepatic lipid accumulation may in turn result in systemic metabolic deregulations. Also, hepatic nonesterified fatty acids can activate the expression of gluconeogenic, β-oxidative, lipogenic and ketogenic genes through PPARs, hence promoting hyperglycaemia, hyperlipidaemia and ketosis. The characterising hormonal background in NAFD consists of hyperinsulinemia, hyperglucagonemia, hypercortisolaemia, growth hormone deficiency and elevated sympathetic tone. Such metabolic and hormonal modifications lead to a positive feedback that may further trigger hepatic steatosis by stimulating lipolysis in adipose tissue, liver lipid uptake, de novo lipogenesis, β-oxidation, lipid export and ketogenesis.
We will now discuss how several hormones are under circadian control and hence how NAFLD could be possibly related to circadian misalignment-mediated hormonal unbalances.
Cortisol
In humans, cortisol production usually rises during night time and peaks in the morning around 07:00-08:00, preparing the endocrine system for waking-associated stress [137, 138] .
Jet lag and unscheduled sleep were shown to increase cortisol levels in humans [139, 140] , leading to several pathologic conditions, such as cardiometabolic diseases, sleep and mood disorders [141] and tumours [142, 143] . Glucocorticoids and cortisol regulated clock-controlled gene expression in the liver, kidney and adipose tissues [144, 145] . Glucocorticoids also work as key modulators for clock resynchronisation in a mouse model of jet lag [146] . Over the last years, some evidences have been collected linking cortisol homeostasis deregulation and NAFLD onset, even if not all the results agree. One study reported that patients with NAFLD have a subtle, chronic overactivity in the HPA axis resulting in subclinical hypercortisolism that might be responsible for the development of NAFLD [147] . On the contrary, another study conducted in 662 women and 662 men was not able to find an association between plasma cortisol concentrations and NAFLD development [148] .
Insulin and ghrelin
In humans, insulin secretion has a zenith at nearly 5:00 p.m. and a nadir at about 4:00 a.m., stimulating anabolism in the active phase. Insulin secretion is under tight clock control, since lack of both CLOCK and BMAL1 leads to hypoinsulinemia [129, 130] , whereas loss of PER and CRY results in hyperinsulinemia [149, 150] . Shift work seems to be responsible for an increase in insulin secretion and a decrease in insulin sensitivity, probably due to a pre-diabetic condition [151, 152] . Insulin and glucose can also regulate the circadian clock. For example, insulin resynchronises the hepatic clock in a three-dimensional rat hepatocyte model and in primary mouse hepatocytes [153, 154] . Moreover, glucose downregulates expression of Per1 and Per2 in cultured rat fibroblasts [155] . The oxyntic cells of the stomach secrete ghrelin before feeding time according to their own circadian clock, independently from light exposure [119] . The main action of ghrelin is appetite stimulation [156] [157] [158] . Normal ghrelin cycle was shown to be disrupted in shift workers, possibly explaining the observed overfeeding [159] . In fact, in mice, ghrelin directly regulated the expression of clock genes in the SCN, thus increasing food intake [160] .
Adiponectin and leptin
Adiponectin is an adipose tissue-secreted adipokine. In humans, adiponectin production peak is observed between 12:00 and 2:00 p.m. [161, 162] . Adiponectin is a wellknown anti-inflammatory and insulin-sensitiser molecule [163] ; its circulating levels were reported to decrease in obese subjects and to increase after weight loss [164, 165] . In rodents fed high-fat diet (HFD), fat mass and adiponectin levels showed an inverse correlation [166, 167] . Mice with an induced metabolic syndrome with hypoadiponectinemia showed a reduced circadian locomotor activity, but an increased activity during the light phase. Also, circadian gene expression was shifted in the liver and skeletal muscle. Recovery of hepatic adiponectin gene expression led to the regaining of the locomotor activity scheme and hepatic clock gene expression [168] .
Leptin is secreted by the white adipose tissue in response to an increase of hepatic glucose levels, and in humans, it peaks during the night. Leptin signals satiety to the appetite centres in the hypothalamus, preventing overfeeding. In humans, HFD was shown to decrease leptin levels, whereas increased fat mass and obesity leads to hyperleptinemia [169] . Moreover, leptin increased Per expression in the SCN of female mice, by enhancing the phase-shifting action of light [170] . In rats, ex vivo, leptin reset SCN clock phase [171] .
Role of gut microbiota
Several findings have been recently collected linking the proper functioning of the circadian machinery to the quality and the functionality of gut microbiota and eventually to the development of metabolic diseases, including NAFLD/NASH [172] .
The importance of the proper functioning of the gut microbiota for our metabolic homeostasis is well described, and the pivotal role played in metabolism regulation as well as in metabolic diseases was recently confirmed [173] . Interestingly, what has emerged over the last 2/3 years is the importance of circadian rhythms in the regulation of our intestinal microbiome.
For example, in mice under regular light/dark (LD) cycles, gut microbiota showed an evident oscillation from both a compositional and functional level in all parts of the intestine. Instead, constant darkness cycles (dark-dark, DD) resulted in a loss of rhythmic cycles in nearly all the intestine. Thus, authors concluded that light exposure is an important upstream factor regulating the proper diurnal cycles of gut microbiota in vivo [174] . It was recently found that under dexamethasone treatment, mice showed marked changes of eating habits and lipid metabolism. Indeed, they accumulated more fats, despite a decreased appetite and body weight, by triggering a deregulation of lipogenic gene expression in both adipose tissue and liver. Interestingly, dexamethasone determined a relevant reduction in the amount and variety of colon microbiome, an increase in inflammatory cell infiltration and a decrease in mucus secretion. Also, dexamethasone induced phase shift or loss of circadian rhythmicity of some clockrelated genes (Bmal1, Clock, Per2, Cry) in the liver, adipose tissue and colon [175] .
A recent study suggested that gut microbiome proper homeostasis might be strictly dependent upon a good sleep quality. In fact, analysis of microbiota composition revealed that 2 days of partial sleep deprivation versus 2 days of normal sleep, increased the Firmicutes/Bacteroidetes ratio and the presence of Coriobacteriaceae and Erysipelotrichaceae families and decreased the abundance of Tenericutes. All these bacteria strains were previously associated with metabolic perturbations in animal or human models. These observations show that short-term sleep loss may affect human microbiome, even if authors suggest prudence and the need for more studies to ascertain how much sleep deprivation may really have an influence on the microbiota, especially in already metabolically compromised individuals [176] .
Some research have also tried to address the question of how the crosstalk between circadian clock and gut microbiome could be explained by a mechanistic point of view. In mice, gut microbiota mediated PPARγ-driven activation of newly oscillatory transcriptional programmes in the liver in response to high-fat diet. Moreover, antibiotic treatment prevented PPARγ-activated transcription in the liver, emphasising the role of gut microbiome in circadiancontrolled hepatic homeostasis [177] . In mice, circadian transcription factor NFIL3 regulates absorption and export of lipids in intestinal epithelial cells controlling microbiome homeostasis. Nfil3 transcription oscillated in intestinal epithelial cells in a circadian manner, and the amplitude of the oscillation is under microbiota control through signal transducer and activator of transcription 3 (STAT3) and the epithelial cell circadian clock [178] .
Worth mentioning is that Enterobacter aerogenes, a species of commensal bacterium of the human gastrointestinal system, is responsive to melatonin. Melatonin increases the magnitude of swarming in E. aerogenes, but not in Escherichia coli or Klebsiella pneumoniae. These observations suggest the presence of a circadian regulation machinery in a non-cyanobacterial prokaryote and that the human circadian system has a deep interconnection with its microbiome through hormonal entrainment of bacterial clocks [179] .
Role of sleeping habits
In rodents, experimental jet lag with long-term light-dark shifting led to decreased body temperature, augmented adiposity, unregulated immune response and tumour development [180] [181] [182] [183] . Induced desynchronisation of light-dark cycles also affected hormonal homeostasis [146, 184, 185] .
In humans, induced sleep-wake misalignment provoked an unregulated secretion of insulin, leptin and norepinephrine, whereas cortisol, epinephrine and glucose kept the usual circadian secretion rhythm [186] . Circadian derangement driven by sleep deprivation raised insulin resistance and inflammation marker levels [187] .
Several authors reported epidemiological evidences linking sleep deprivation and bad sleeping habits with NAFLD/ NASH, even if so far the connection is unclear and there is no agreement between all the different studies, thus suggesting prudence in drawing conclusions, and the need for more investigations. For example, a Japanese study showed a higher prevalence of NAFLD in patients with less than 5 h of sleep, whereas more than 7 h of sleep reduced the risk of NAFLD. In a Korean study involving 45,000 adults, less than 5 h of sleep increased NAFLD prevalence in adult females [188] . Similarly, another Japanese study demonstrated a higher risk of NAFLD associated with short sleep duration in female subjects [189] . Two Italian studies found analogous results in teenagers and adults [190, 191] . In another report, patients with NAFLD were found to have shorter sleep duration compared with the healthy group, and additionally, longer sleep latency was found in NAFLD patients [192] . It was also shown that optimal sleep duration was significantly associated with a lower probability of advanced fibrosis [193, 194] . On the contrary, a Japanese study performed on 2400 subjects reported that short sleep duration did not lead to increased risk of NAFLD in females, but was correlated with a decreased risk in males. A study conducted on about 9000 Chinese adults revealed an increased risk in NAFLD incidence with sleep durations longer than 8 h per night, but no with less than 7 h sleep [188] . So far, no clear association has been found between shift work and increased prevalence of NAFLD. A Chinese study reported that NAFLD was more frequent in daytime nappers, with a dose-dependent relationship with the duration of napping [195] . An increased NAFLD frequency was also observed in patients eating frequently nocturnal meals [192] .
On the same line, some studies showed that the dawn-tosunset Ramadan fasting, which is comparable to timerestricted feeding mice model, resulted in a significant improvement in body mass index, serum lipid profiles and oxidative stress parameters. Authors concluded that dawn-tosunset fasting could be a possible way to deal with obesity, metabolic syndrome and NAFLD problems [196] .
Several articles also tried to gain insights into the possible molecular mechanisms linking circadian clock disruption and NAFLD development. A study carried out in mice proposed that the misalignment between the master clock regulator in SCN and the peripheral clocks (generated by shifting the eating schedule from the normal active phase to the rest phase) could be responsible for a metabolic syndrome-like pathology, similarly to that exhibited by shift workers [197] . Another study showed that in mice major unfolded protein response (UPR) pathways were activated in a rhythmical manner in the liver under normal physiological conditions. This rhythm could be affected by maternal obesogenic feeding and postnatal intake, showing a possible link between circadian clock, feeding habits and intracellular regulation pathways [198] . Also, environmental uncoupling of the light-dark phases, the so-called chronic circadian disruption (CCD), and the ablation of an important metabolic transcriptional co-regulator, Steroid Receptor Coactivator-2 (SRC-2), were suggested to lead to NAFLD development in mice. The combined effect of SRC-2 −/− and CCD resulted in a stronger phenotype that matched with human non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC) gene signatures. Both CCD or SRC-2 ablation produced an ageing phenotype leading to increased mortality. Authors concluded that SRC-2 could represent an important link between the lightdependent behavioural activities and the hepatic metabolic homeostasis [199] . Interestingly, it has been shown that NAFLD/NASH/ HCC progression can be induced by jet lag-driven genome-wide gene deregulations and large-scale liver metabolic dysfunctions, with derangements of nuclear receptor-controlled cholesterol/bile acid and xenobiotic metabolism. This pathophysiological lack of farnesoid X receptor (FXR) considerably increased enterohepatic bile acid levels and jet lag-induced HCC, whereas loss of constitutive androstane receptor (CAR), a well-characterised hepatic tumour promoter, halted NAFLD-induced hepatocarcinogenesis. Circadian misalignment stimulated CAR by enhancing cholestasis, peripheral clock disruption and sympathetic dysfunction [200] .
The above-mentioned observations, together with what we described about the connection between the circadian clock and the regulation of the hormonal and metabolic homeostasis, in particular of the liver, suggest that our internal rhythms might play a key role in the development of this pathology.
Role of circadian rhythms in NASH/HCC
Recent research has examined the possible involvement of circadian rhythms in determining the progression from NAFLD/NASH to HCC that is worth describing.
Cirrhosis
Recent observations indicate a possible pathogenic link between deregulation of circadian rhythms and cirrhosis onset. Liver cirrhosis was reported to lead to portal hypertension and dysregulation of circadian clock machinery, which resulted in delayed sleep-wake cycles, modifications of circulating melatonin and cortisol and daytime sleepiness [201] . Moreover, cirrhotic individuals were reported to have atypical circadian rhythms of fibrinolysis, hepatic catabolism of melatonin and high arterial blood pressure [202] . In mice, carbon tetrachloride-induced acute liver fibrosis resulted in unregulated expression of Cry2, Pparα and Ror [203] . In addition, in Per2 knockout mice, carbon tetrachloride treatment produced a more severe pattern of liver fibrosis when compared with controls [204] . Carbon tetrachloride-activated hepatic stellate cells transdifferentiate to fibrogenic myofibroblast-like cells, resulting in liver fibrosis and cirrhosis. Nuclear receptor activation of PPARγ and REV-ERBα led to hepatic stellate cell inhibition [205] .
Cirrhosis can also be caused by cholestasis, namely the hepatic accumulation of bile acid. Per1 and Per2 doubleknockout mice displayed high levels of bile acids in both serum and liver and a deregulation in bile acid synthesis and in transport genes, such as Cyp7a1 [206] . Bile ductligated Per2 −/− mice presented severe cholestasis, bile infarcts, increased fibrosis-related gene expression and extracellular matrix deposition [207] . Notably, if these rats were kept in continuous darkness, the resulting increase in melatonin synthesis reduced fibrosis and improved liver function [208] .
HCC
Circadian machinery was suggested to exert a tight control on cell cycle and cell proliferation, and on tumour suppressor gene and oncogene expression [209, 210] . Per2
mice, Bmal1 ± mice and Cry1 −/− -and Cry2 −/− -deficient mice were more prone to develop tumours, both spontaneous and radiation-induced [211, 212] . Mice under simulated chronic jet lag easily developed diethylnitrosamine (DEN)-induced liver cancer [182] . Unscheduled expression of clock genes was correlated with HCC onset and development in humans [213] . In mice, unrhythmic clock expression was associated with colorectal liver metastasis development [214] . Furthermore, in mice, low oscillation amplitude of Per1 expression and reduced food entrainment were shown in DEN-induced HCC [215] . Likewise, a functional polymorphism in PER3 decreased the survival of patient with HCC [216] .
Possible circadian-related therapeutic interventions
Our biological clock is deeply interconnected with our endocrine homeostasis. Hence, perturbations of our hormonal balance can result in pathologic consequences. The search for new therapeutic approaches for the increased incidence of circadian-related diseases will be important in the future and may result in an improvement of therapeutic strategies for NAFLD, NASH and HCC. A combination of genetic approaches, targeting clock genes and behavioural techniques aiming at changing wrong eating and sleeping habits has been proposed. It is however clear that these approaches are not easy to be put in practice. The development of new molecules targeting clock proteins may prove useful in this respect. So far, some molecules with potential beneficial effects have been discovered: Two approaches are becoming diffused for the treatment of circadian and circadian-related disorders: light therapy and chronotherapy.
Light therapy in the morning was proven to be effective in shifting forward the circadian rhythm and sleep phase. Short (30 min) blue light pulses in the morning restored sleep integrity and quality and recovered performance impairment. This effect was not observed with the amber light [219] . In a smallcohort human clinical trial, intermittent light shifted circadian phase more effectively than continuous light. The interstimulus interval between flashes was key in determining the delay in the circadian rhythm. Light pulses did not change melatonin secretion or state of alertness [220] .
Chronotherapy is described as the approach employed to maximise the efficacy and minimise side effects when drugs are administered in accordance with circadian rhythms. Chronopharmacology can be defined as a particular branch of chronotherapy that, according to the circadian rhythms, tries to define the best timing for drug administration, absorption, distribution, metabolism, and excretion of administered xenobiotics. Physiological parameters, such as hormone levels, gastric pH, liver enzyme activity and hepatic and renal blood flow, show a circadian pattern; hence, drug efficacy will be time-dependent [221] . Until now, chronotherapy/ chronopharmacology has been tried for different kinds of diseases, such as hypertension [222] [223] [224] [225] [226] , rheumatoid arthritis [227] , inflammatory diseases [228, 229] , depression [230] and tumours [231, 232] . Even if evidences have been reported about the effectiveness of such approaches, additional clinical trials will be needed to fully understand their real biological and therapeutic relevance. Anyway, this kind of approaches may result helpful in the therapeutic treatment of metabolic diseases including NAFLD. So far, the best way in which these views could be applied as a therapeutic intervention in NAFLD is in trying to give to patients more scheduled eating habits, the so-called chrononutrition. In fact, as we described above, peripheral clocks are under strict regulation by feeding-fasting rhythms [46, 233] . In addition, diet-induced insulin secretion can reset liver clocks, whilst oxyntomodulin is involved in resetting peripheral clocks [153, 154, 234] . Both insulin and oxyntomodulin can upregulate Per2 expression in mouse liver [153, 154, 234, 235] .
The nutritional composition of food seems also to play a role in peripheral clock entrainment. For example, starches and fish oil-induced insulin secretion were reported to enhance peripheral clock entrainment by an insulin signallingmediated mechanism [236] [237] [238] . Interestingly, food ingestion after long fasting periods can entrain peripheral clocks more efficiently compared to having a meal after shorter periods of fasting [239, 240] . The time regulation of food intake without caloric restriction was shown to be beneficial in preventing diet-induced obesity in both humans and mice and in reducing obesity caused by a simulated shift work pattern in mice [241] [242] [243] . Interestingly, in restricted fed and hence fasting mice, nocturnin expression is stimulated in white adipose tissue [244] . Notably, caffeine lengthens the circadian rhythm in vitro and in vivo and induces a phase-shift in the liver clock depending on the time when it is consumed [245, 246] . In humans, caffeine consumption 3 h before habitual sleeping time can postpone the phase of melatonin rhythm [247] .
Conclusions
Circadian rhythms are now recognised as an essential piece of the complex puzzle that depicts our physiologic homeostasis. The knowledge about the deep crosstalk between circadian clock, energy metabolism and hormonal homeostasis has been, step-by-step, increased over the last two decades, addressing the role of the central clock in the coordination the peripheral organ clocks. Several genes involved in metabolism regulation under circadian clock have been discovered. Thus, any perturbation of such a delicate equilibrium may result in the development of severe pathological conditions. For this reason, the research in this field is very active, and new discoveries will prove helpful and beneficial not only to improve scientific knowledge, but also to improve public health.
In fact, over the last decades, an increasing percentage of the general population modified their lifestyle. Sleep reduction or a diminished sleep quality is becoming very common, for example, due to shift work or frequent trans-meridian flights, or to the so called Bsocial jetlag^, i.e. to the modification of sleeping habits during the weekends. Even if circadian rhythm deregulation was shown to be involved in the increasing incidence of metabolic, endocrine and cardiovascular diseases and tumours, it is not plain to assess the real part that circadian disruption has in the development of such diseases. Indeed, bad life habits, such as smoking, alcohol consumption or scarcity of physical activity, could have arisen as secondary consequences of shift work or frequent trans-meridian flights. The picture is truly not clear, and more research will be required to completely understand it.
KL001
Inhibits ubiquitin-dependent degradation of CRY, resulting in lengthening of the circadian period. Reduced gluconeogenesis in vitro [217] SR9009& SR9011 REV-ERBα agonists. Decrease Cry2 rhythms, increase Per2 rhythms and shift Bmal1 ones. SR9009 also decreased adiposity and improves dyslipidaemia and hyperglycaemia in a mouse obesity model [118] .
Longdaysin
Increases circadian period in vitro and in vivo triggering PER1 degradation by regulation of several kinases, particularly CKIα [218] .
In general, maintaining the circadian machinery in a good working condition may definitively help in preventing the development of many diseases. In this perspective, new public health strategies aiming at increasing population awareness about risks of an unscheduled lifestyle, in combination with the discovery of new molecules that may tune up the clock molecular machinery, might help in handling this new growing pandemic of metabolic diseases. In addition, approaches like light therapy and chronotherapy may prove useful in such a perspective. Eventually, a better knowledge of how the biological clock is linked with metabolic processes and carcinogenesis may hopefully provide the opportunity not only for treatment but also for prevention of metabolic liver diseases and HCC. Whilst more clinical studies will be undoubtedly needed, how to get a better liver health and prevent cancer could be obtained just starting with keeping healthy habits. 
